View on Pubmed.gov 42539970 | View on doi.org 10.1016/j.ero.2... | View the free full text Full text
Patient awareness and perception of cardiovascular risk in rheumatic and musculoskeletal diseases: results from an international survey.
- Department of Clinical Medicine, Life, Health and Environmental Science, Internal Medicine and Nephrology Division, University of L'Aquila, L'Aquila, Italy.
- Area of Immunology, Department of Functional Biology, Faculty of Medicine, University of Oviedo, Oviedo, Spain.
- Department of Metabolism, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
- Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
- Institute of Outcomes Research, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
- Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Vienna, Austria.
- EULAR PARE, Zurich, Switzerland.
- Danish Center for Expertise in Rheumatology (CeViG), Danish Hospital for Rheumatic Diseases, University Hospital of Southern Jutland, Sonderborg, Denmark.
- Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
- Thrombosis and Haemostasis, Guy's and St Thomas NHS Foundation Trust, London, UK.
- Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
- Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, Italy.
- Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
- Department of Rheumatology, Reade, Amsterdam, The Netherlands.
EULAR Cardiovascular in inflammatory arthritis (CVIIA) Study Group members
Abstract
OBJECTIVES
Inflammatory rheumatic and musculoskeletal diseases (RMDs) are hallmarked by an increased risk of cardiovascular (CV) disease compared with the general population. Evidence suggests that CV risk remains under-recognised and underdiscussed in routine care, although data on patient experience is lacking. We aimed to assess awareness, perceptions, and experiences regarding CV risk and prevention in patients with RMDs.
METHODS
An anonymous, online survey was codesigned by rheumatologists, researchers, and patient research partners in English language and translated into 9 languages. This was distributed through patient organisations/forums and social media.
RESULTS
A total of 951 patients with RMDs from 43 countries (mainly females, aged 50-70 years, and with a diagnosis of rheumatoid arthritis, spondyloarthritis, or systemic lupus erythematosus) completed the survey. Although 68% of respondents acknowledged an increased CV risk in RMDs, and traditional CV risk factors were recognised by up to 60% of the participants, knowledge of disease-specific contributors (eg, disease activity) to CV risk was limited. Only 35% of respondents had ever discussed CV risk with a healthcare provider, mainly rheumatologists or cardiologists, and the content primarily focused on lifestyle advice. Lack of awareness on the topic relevance (38%), perceived complexity of the topic (25%), limited time of clinical visits (35%), and lack of informative materials (33%) emerged as the main key barriers among those poorly/not informed.
CONCLUSIONS
This large, multinational survey demonstrates substantial gaps in CV risk awareness, knowledge, and patient-provider communication among patients with RMDs. These figures support the development of structured, patient-centred educational strategies and enhanced multidisciplinary communication schemes to improve CV prevention in RMDs.
References
Conrad N., Verbeke G., Molenberghs G., Goetschalckx L., Callender T., Cambridge G., et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet. 2022;400(10354):733–743.
Mortensen M.B., Jensen J.M., Rønnow Sand N.P., Kragholm K., Blaha M.J., Grove E.L., et al. Association of autoimmune diseases with coronary atherosclerosis severity and ischemic events. J Am Coll Cardiol. 2024 Jun 25;83(25):2643–2654.
Porsch F., Binder CJ. Autoimmune diseases and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2024 Nov;21(11):780–807.
Nygaard L., Polcwiartek C., Nelveg-Kristensen K.E., Carlson N., Kristensen S., Torp-Pedersen C., et al. Increased risk of cardiovascular disease preceding diagnosis of incident ANCA-associated vasculitis: a Danish nationwide study. Rheumatology (Oxford) 2024 May 2;63(5):1313–1321.
Conflict of interest statement
All authors declare they have no competing interests.
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
Copyright
© 2026 The Author(s).